The landscape of dementia diagnosis has evolved significantly with the appearance of subtle biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly tests which can detect Alzheimer's pathology several years prior to symptoms arise. Even though these technological improvements represent amazing progress in being familiar with neurodegenerative conditions, https://talibh318fpy8.blogsumer.com/profile